BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2019

View Archived Issues

Too much of a good thing foils heart repair

Read More

Voxelotor improves anemia in adolescents with sickle cell disease

Read More

Plasma kallikrein inhibitor VE-4840 shows preclinical potential for treating diabetic retinopathy

Read More

Long non-coding RNA CASC9 has an oncogenic role in breast cancer

Read More

IMVT-1401 demonstrates promising safety, PK and PD in healthy subjects

Read More

Flavonoid promotes pleiotropic neuroprotective effects

Read More

CAR fusion proteins targeting Strep-tagged peptides patented by Fred Hutchinson, TUM

Read More

Updated data presented from phase Ib/II study of RG-6206 in boys with DMD

Read More

WuXi Biologics describes new bispecific antibodies against EGFR and PD-1

Read More

Novel biomarkers of clinical efficacy of bevacizumab in the treatment of gastric cancer

Read More

NB-01 leads to statistically significant improvements in diabetic neuropathic pain

Read More

TRAF2 and NCK-interacting protein kinase inhibitors discovered at Silverback Therapeutics

Read More

Ajinomoto identifies new sweet receptor antagonists

Read More

Exosomal PD-L1 identified as a cancer therapeutic target

Read More

Blueprint Medicines discloses activin receptor type-1 inhibitors

Read More

ORIC Pharmaceuticals initiates phase Ib study of ORIC-101 in advanced solid tumors

Read More

Promising topline results announced from phase IIb study of seltorexant in major depressive disorder

Read More

Oncolytic adenovirus with specificity for ARMS cells presented

Read More

FDA approves Eylea to treat all stages of diabetic retinopathy

Read More

NIH grant supports Ichor's development of antibodies against hantavirus infections

Read More

DSMB 36-month review of phase III RESOLVE-IT trial of elafibranor in NASH recommends continuation

Read More

Mitochondrial DNA polymorphism linked to infant bronchopulmonary dysplasia

Read More

P-MUC1C-101 shows robust antitumor effects in orthotopic breast tumor model

Read More

Sevuparin fails to show meaningful benefit in phase II trial to manage VOC in sickle cell disease

Read More

Confirmatory phase III trial of dasiglucagon in severe hypoglycemia meets primary endpoint

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing